RxDoctor Payments Data

Lillian Shores, PA

Physician Assistant · Wilmington, NCNPI 1073538245

Payments from drug & device makers

$3,716in general payments, 2019–2025

Across 221 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$260
  • Gilead$195
  • Johnson & Johnson$188
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$172
  • Nestle Healthcare Nutrition Inc.$170
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,57696%
  • Education$1163%
  • Gifts$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,716 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$68,556
Medicare patients
425
Services billed
1,395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab13$88,550
ZenpepLipase/Protease/Amylase20$80,008
RinvoqUpadacitinib11$79,258
LinzessLinaclotide44$47,494
MovantikNaloxegol Oxalate35$23,387
MotegrityPrucalopride Succinate16$12,236
Dexlansoprazole DrDexlansoprazole21$8,496
Esomeprazole Magnesium55$4,101
Budesonide EcBudesonide12$2,245
Famotidine95$2,194
Colestipol Hcl11$1,938
Rabeprazole Sodium27$1,476
Pantoprazole Sodium68$1,462
Omeprazole144$1,421
Dicyclomine Hcl43$1,327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Linzess$1,511$126,75255 claims
Aimmune Therapeutics, Inc.Zenpep$59$80,00820 claims
Redhill Biopharma Inc.Movantik$16$23,38735 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$168$12,23616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →